Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.8247USD
−19.83 MUSD
11.79 M
About Bellerophon Therapeutics, Inc.
Sector
CEO
Craig R. Jalbert
Headquarters
Warren
Website
Employees (FY)
18
Founded
2009
FIGI
BBG007X1TKD5
Bellerophon Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of products that address significant unmet medical needs in the treatment of cardiopulmonary diseases. Its product pipeline includes PH-ILD, PH-COPD, INOpulse and PH-Sarc. The company was founded in 2009 and is headquartered in Warren, NJ.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of BLPH is 0.0563 USD — it hasn't changed in the past 24 hours. Watch Bellerophon Therapeutics, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Bellerophon Therapeutics, Inc. stocks are traded under the ticker BLPH.
BLPH stock hasn't changed in a week, the month change is a 3.92% fall, over the last year Bellerophon Therapeutics, Inc. has showed a 99.26% decrease.
BLPH reached its all-time high on Feb 27, 2015 with the price of 193.8000 USD, and its all-time low was 0.0290 USD and was reached on Nov 17, 2023. View more price dynamics on BLPH chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
BLPH stock is 1.73% volatile and has beta coefficient of 2.58. Track Bellerophon Therapeutics, Inc. stock price on the chart and check out the list of the most volatile stocks — is Bellerophon Therapeutics, Inc. there?
Today Bellerophon Therapeutics, Inc. has the market capitalization of 688.70 K, it has increased by 7.26% over the last week.
Yes, you can track Bellerophon Therapeutics, Inc. financials in yearly and quarterly reports right on TradingView.
Bellerophon Therapeutics, Inc. is going to release the next earnings report on May 24, 2024. Keep track of upcoming events with our Earnings Calendar.
BLPH net income for the last quarter is −1.92 M USD, while the quarter before that showed −5.14 M USD of net income which accounts for 62.61% change. Track more Bellerophon Therapeutics, Inc. financial stats to get the full picture.
No, BLPH doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of May 24, 2024, the company has 18.00 employees. See our rating of the largest employees — is Bellerophon Therapeutics, Inc. on this list?
Like other stocks, BLPH shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Bellerophon Therapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Bellerophon Therapeutics, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Bellerophon Therapeutics, Inc. stock shows the sell signal. See more of Bellerophon Therapeutics, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.